1. Pyott S.M., Schwarze U., Christiansen H.E., Pepin M.G. Mutations in PPIB (cyclophilin B) delay type I procollagen chain association and result in perinatal lethal to moderate osteogenesis imperfecta phenotypes. Hum Mol Genet. 2011;20(8):1595–1609. doi: 10.1093/hmg/ddr037. 53 2. Rauch F., Moffatt P., Cheung M., Roughley P., Lalic L., Lund A.M., Ramirez N., Fahiminiya S., Majewski J., Glorieux F.H. Osteogenesis imperfecta type V: marked phenotypic variability despite the presence of theIFITM5c.–14C>T mutation in all patients. J Med Genet. 2012;50(1):21– 24. doi: 10.1136/jmedgenet-2012-101307. 3. Cho TJ, Lee KE, Lee SK. A single recurrent mutation in the 5’-UTR of IFITM5 causes osteogenesis imperfecta type V. Am J Hum Genet. 2012;91(2):343–348. doi: 10.1016/j.ajhg.2012.06.005. 4. Marini J.C., Reich A., Smith S.M. Osteogenesis imperfecta due to mutations in noncollagenous genes: lessons in the biology of bone formation. Curr Opin Pediatr. 2014;26(4):500–507. doi: 10.1097/MOP.0000000000000117. 5. Marini J.C., Forlino A., Cabral W.A., Barnes A.M., San Antonio J.D., Milgrom S., Hyland J.C., Körkkö J., Prockop D.J., De Paepe A., Coucke P., Symoens S., Glorieux F.H., Roughley P.J., Lund A.M., Kuurila-Svahn K., Hartikka H., Cohn D.H., Krakow D., Mottes M., Schwarze U., Chen D., Yang K., Kuslich C., Troendle J., Dalgleish R., Byers P.H. Consortium for osteogenesis imperfecta mutations in the helical domain of type I collagen: regions rich in lethal mutations align with collagen binding sites for integrins and proteoglycans. Hum Mutat. 2007 Mar;28(3):209-21. 6. Lindahl K, Åström E, Rubin CJ, Grigelioniene G, Malmgren B, Ljunggren Ö, Kindmark A. Genetic epidemiology, prevalence, and genotype-phenotype correlations in the Swedish population with osteogenesis imperfecta. Eur J Hum Genet. 2015 Aug;23(8):1042-50. doi: 10.1038/ejhg.2015.81. Epub 2015 May 6. 7. Hackley, L., & Merritt, L. (2008). Osteogenesis Imperfecta in the Neonate. Advances in Neonatal Care, 8(1), 21–30. doi:10.1097/01.anc.0000311013.71510.41. 8. Rossi V, Lee B, Marom R. Osteogenesis imperfecta: advancements in genetics and treatment. Curr Opin Pediatr. 2019 Dec;31(6):708-715. doi: 10.1097/MOP.0000000000000813 9. Osteogenesis imperfecta: An overview https://www.uptodate.com/contents/osteogenesisimperfecta-anoverview?search=Osteogenesis%20imperf&source=search_result&selectedTitle=1~69&usage_type= default&display_rank=1 (last updated: May 04, 2021) 10. Kruse, Richard W. Osteogenesis Imperfecta [electronic Resource] : A Case-Based Guide to Surgical Decision-Making and Care / Edited by Richard W. Kruse. 1st ed. 2020. Cham: Springer International Publishing, 2020 11. Marini JC, Forlino A, Bachinger HP, et al. Osteogenesis imperfecta. Nat Rev Dis Primers. 2017;3:17052, 54 12. Ben Amor IM, Glorieux FH, Rauch F. Genotype-phenotype correlations in autosomal dominant osteogenesis imperfecta. J Osteoporos. 2011;2011:540178, Maioli M, Gnoli M, Boarini M, et al. Genotype-phenotype correlation study in 364 osteogenesis imperfecta Italian patients. Eur J Hum Genet. 2019;27(7):1090–100 13. Delmas, P. D., Eastell, R., Garnero, P., Seibel, M. J., & Stepan, J. (2000). The Use of Biochemical Markers of Bone Turnover in Osteoporosis. Osteoporosis International, 11(0), S2– S17. doi:10.1007/s001980070002. 14. Ipach I., Kluba T., Wolf P., Pontz B., Mittag F. (2012). The influence of ibandronate treatment on bone density and biochemical bone markers in patients with osteogenesis imperfecta. Orthopedic Reviews, 4(3), 29. doi:10.4081/or.2012.e29. 15. Seibel MJ. Biochemical markers of bone turnover: part I: biochemistry and variability. Clin Biochem Rev. 2005;26(4):97–122. 16. Misra M., Pacaud D., Petryk A., Collett-Solberg P.F., Kappy M. Vitamin D deficiency in children and its management: Review of current knowledge and recommendations Pediatrics 2008; 122:398-417. 17. Vasikaran S, Eastell R, Bruyere O, et al. Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards. Osteoporosis Int. 2011;22:391–420. doi: 10.1007/s00198-010-1501-1. 18. Eastell R, Walsh JS. Bone: microarchitecture of bone predicts fractures in older women. Nat Rev Endocrinol. 2018;14(5):255–256. doi: 10.1038/nrendo.2018.27. 19. Kerkeni S, Kolta S, Fechtenbaum J, Roux C (2009) Spinal deformity index (SDI) is a good predictor of incident vertebral fractures. Osteoporos Int 20:1547–1552. 20. Sanfélix-Genovés, J., Arana, E., Sanfélix-Gimeno, G., Peiró, S., Graells-Ferrer, M., & VegaMartínez, M. (2011). Agreement between semi-automatic radiographic morphometry and Genant semi-quantitative method in the assessment of vertebral fractures. Osteoporosis International, 23(8), 2129–2134. doi:10.1007/s00198-011-1819-3. 21. Sam J.E., Dharmalingam M. Osteogenesis imperfecta. Indian J Endocrinol Metab. 2017 NovDec;21(6):903-908. doi: 10.4103/ijem.IJEM_220_17. 22. Sillence D, Senn A, Danks D: Genetic heterogeneity in osteogenesis imperfecta. J Med Genet 1979; 16: 101-116; 23. Sillence DO. Craniocervical abnormalities in osteogenesis imperfecta: genetic and molecular correlation. Pediatr Radiol. 1994;24(6):427-30. doi: 10.1007/BF02011910; 55 24. Arponen H, Mäkitie O, Haukka J, et al: Prevalence and natural course of craniocervical junction anomalies during growth in patients with osteogenesis imperfecta. J Bone Miner Res 2012;27(5): 1142-1149 25. Meyer S, Villarreal M, Ziv I: A three-level fracture of the axis in a patient with osteogenesis imperfecta. A case report. Spine 11:505–506, 1986; 26. Rao S, Patel A, Schildhauer T: Osteogenesis imperfecta as a differential diagnosis of pathologic burst fractures of the spine. A case report. Clin Orthop Relat Res 289:113– 117, 1993 27. Maegen J Wallace, Richard W Kruse, Suken A Shah The Spine in Patients With Osteogenesis Imperfecta. J Am Acad Orthop Surg 2017 Feb;25(2):100-109. doi: 10.5435/JAAOS-D-15-00169 28. Benson DR, Donaldson DH, Millar EA. The spine in osteogenesis imperfecta. J Bone Joint Surg [Am] 1978;60:925–9 29. Benson DR, Newman DC. The spine and surgical treatment in osteogenesis imperfecta. Clin Orthop 1981;159:147–5 30. Anissipour AK, Hammerberg KW, Caudill A, et al: Behavior of scoliosis during growth in children with osteogenesis imperfecta. J Bone Joint Surg Am 2014;96(3): 237-243 31. Verra WC, Pruijs HJ, Beek EJ, Castelein RM: Prevalence of vertebral pars defects (spondylolysis) in a population with osteogenesis imperfecta. Spine (Phila Pa 1976) 2009;34(13):1399-1401 32. Hatz D, Esposito PW, Schroeder B, Burke B, Lutz R, Hasley BP: The incidence of spondylolysis and spondylolisthesis in children with osteogenesis imperfecta. J Pediatr Orthop 2011;31(6):655-660. 33. Adami, S., Gatti, D., Colapietro, F., Fracassi, E., Braga, V., Rossini, M., & Tatò, L. (2003). Intravenous Neridronate in Adults With Osteogenesis Imperfecta. Journal of Bone and Mineral Research, 18(1), 126–130. doi:10.1359/jbmr.2003.18.1.126. 34. Chougui K, Addab S, Palomo T, Morin SN, Veilleux LN, Bernstein M, Thorstad K, Hamdy R, Tsimicalis A. Clinical manifestations of osteogenesis imperfecta in adulthood: An integrative review of quantitative studies and case reports. Am J Med Genet A. 2020 Apr;182(4):842-865. doi: 10.1002/ajmg.a.61497, 35. Simm PJ, Biggin A, Zacharin MR, Rodda CP, Tham E, Siafarikas A, Jefferies C, Hofman PL, Jensen DE, Woodhead H, Brown J, Wheeler BJ, Brookes D, Lafferty A, Munns CF; APEG Bone 56 Mineral Working Group. Consensus guidelines on the use of bisphosphonate therapy in children and adolescents. J Paediatr Child Health. 2018 Mar;54(3):223-233, 36. Shapiro JR, Thompson CB, Wu Y, Nunes M, Gillen C. Bone mineral density and fracture rate in response to intravenous and oral bisphosphonates in adult osteogenesis imperfecta. Calcif Tissue Int. 2010 Aug;87(2):120-9. doi: 10.1007/s00223-010-9383-y. Epub 2010 Jun 11 37. Rolvien T., Stürznickel J., Schmidt F.N., Butscheidt S., Schmidt T., Busse B., Mundlos S., Schinke T., Kornak U., Amling M., Oheim R. Comparison of Bone Microarchitecture Between Adult Osteogenesis Imperfecta and Early-Onset Osteoporosis. Calcif Tissue Int. 2018 Nov;103(5):512-521. doi: 10.1007/s00223-018-0447-8. 38. Sakka SD, Cheung MS. Management of primary and secondary osteoporosis in children. Ther Adv Musculoskelet Dis. 2020 Nov 2;12:1759720X20969262 39. Kocijan R., Muschitz C., Haschka J., Hans D., Nia A., Geroldinger A., Ardelt M., Wakolbinger R., Resch H. (2015). Bone structure assessed by HR-pQCT, TBS and DXL in adult patients with different types of osteogenesis imperfecta. Osteoporosis International, 26(10), 2431– 2440. doi:10.1007/s00198-015-3156-4. 40. ., Hald J. D., Hansen S., Gram J., Langdahl B., Abrahamsen B., Brixen K. (2012). Bone geometry, density, and microarchitecture in the distal radius and tibia in adults with osteogenesis imperfecta type I assessed by high-resolution pQCT. Journal of Bone and Mineral Research, 27(6), 1405–1412. doi:10.1002/jbmr.1592. 41. Pickhardt P.J., Lee L.J., Muñoz del Rio A., Lauder T., Bruce R.J., Summers R.M., Pooler B.D., Binkley N. (2011). Simultaneous screening for osteoporosis at CT colonography: Bone mineral density assessment using MDCT attenuation techniques compared with the DXA reference standard. Journal of Bone and Mineral Research, 26(9), 2194–2203. doi:10.1002/jbmr.428. 42. Sule G., Campeau P.M., Zhang V.W., Nagamani S.C., Dawson B.C., Grover M., Bacino C.A., Sutton V.R., Brunetti-Pierri N., Lu J.T., Lemire E., Gibbs R.A., Cohn D.H., Cui H., Wong L.J., Lee B.H. Next-generation sequencing for disorders of low and high bone mineral density. Osteoporos Int 2013; 24:2253–2259. 43. Rauch F., Lalic L., Glorieux F.H., Moffatt P., Roughley P. Targeted sequencing of a pediatric metabolic bone gene panel using a desktop semiconductor next-generation sequencer. Calcif Tissue Int 2014; 95:323–331. 44. Palomo T., Vilaça T., & Lazaretti-Castro M. Osteogenesis imperfecta. Current Opinion in Endocrinology & Diabetes and Obesity 2017, 24(6), 381–388.doi:10.1097/med.0000000000000367. 45. Steiner R, Adsit J, Basel D. COL1A1/2-Related Osteogenesis Imperfecta. Last Revision: May 6, 2021 https://www.ncbi.nlm.nih.gov/books/NBK1295 57 46. Viora E., Sciarrone A., Bastonero S., Errante G., Campogrande M., Botta G., Franceschini P. Increased nuchal translucency in the first trimester as a sign of osteogenesis imperfecta. Am J Med Genet. 2002 May 15;109(4):336-7. doi: 10.1002/ajmg. 47. Marini J.C., Cabral W.A., Barnes A.M. Null mutations in LEPRE1 and CRTAP cause severe recessive osteogenesis imperfecta. Cell Tissue Res. 2010;339(1):59–70. doi: 10.1007/s00441-009- 0872-0. 48. Cozzolino, M., Perelli, F., Maggio, L., Coccia, M. E., Quaranta, M., Gizzo, S., & Mecacci, F. (2016). Management of osteogenesis imperfecta type I in pregnancy; a review of literature applied to clinical practice. Archives of Gynecology and Obstetrics, 293(6), 1153–1159. doi:10.1007/s00404- 016-4012-2. 49. Approach to prenatal diagnosis of the lethal skeletal dysplasias Phyllis Glanc, MD, FRCPC, FACR, David Chitayat, MD, FACMG, FCCMG, FRCPC last updated: May 11, 2020 https://www.uptodate.com/contents/approach-to-prenatal-diagnosis-of-the-lethal-skeletaldysplasias?search=Approach%20to%20prenatal%20diagnosis%20of%20the%20lethal%20skeletal% 20dysplasias&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1 50. Lena L, Wekre LL, Kjensli A, Aasand K, Falch JA, Eriksen EF. Spinal deformities and lung function in adults with osteogenesis imperfecta. Clin Respir J. 2014 Oct;8(4):437 51. LoMauro A, Fraschini P, Pochintesta S, Romei M, D'Angelo MG, Aliverti A. Ribcage deformity and the altered breathing pattern in children with osteogenesis imperfecta. Pediatr Pulmonol. 2018 Jul;53(7):964-972; 52. Osteogenesis Imperfecta Joan C. Marini, MD, PhD and An N. Dang Do, MD, PhD. Last Update: July 26, 2020. https://www.ncbi.nlm.nih.gov/books/NBK279109/ 53. Storoni S, Treurniet S, Micha D, Celli M, Bugiani M, van den Aardweg JG, Eekhoff EMW. Pathophysiology of respiratory failure in patients with osteogenesis imperfecta: a systematic review. Ann Med. 2021 Dec;53(1):1676-1687. doi: 10.1080/07853890.2021.1980819 54. Tam A, Chen S, Schauer E, Grafe I, Bandi V, Shapiro JR, Steiner RD, Smith PA, Bober MB, Hart T, Cuthbertson D, Krischer J, Mullins M, Byers PH, Sandhaus RA, Durigova M, Glorieux FH, Rauch F, Reid Sutton V, Lee B; Members of the Brittle Bone Disorders Consortium, Rush ET, Nagamani SCS. A multicenter study to evaluate pulmonary function in osteogenesis imperfecta. Clin Genet. 2018 Dec;94(6):502-511. doi: 10.1111/cge.13440, 58 55. Folkestad L, Hald JD, Gram J, Langdahl BL, Hermann AP, Diederichsen AC, Abrahamsen B, Brixen K. Cardiovascular disease in patients with osteogenesis imperfecta - a nationwide, registerbased cohort study. Int J Cardiol. 2016 Dec 15;225:250-257, 56. Thiele F, Cohrs CM, Flor A, Lisse TS, Przemeck GK, Horsch M, Schrewe A, Gailus-Durner V, Ivandic B, Katus HA, Wurst W, Reisenberg C, Chaney H, Fuchs H, Hans W, Beckers J, Marini JC, Hrabé de Angelis M. Cardiopulmonary dysfunction in the Osteogenesis imperfecta mouse model Aga2 and human patients are caused by bone-independent mechanisms. Hum Mol Genet. 2012 Aug 15;21(16):3535-45]. 57. Bronheim R, Khan S, Carter E, Sandhaus RA, Raggio C. Scoliosis and Cardiopulmonary Outcomes in Osteogenesis Imperfecta Patients. Spine (Phila Pa 1976). 2019 Aug 1;44(15):1057- 1063 58. Folkestad L. Mortality and morbidity in patients with osteogenesis imperfecta in Denmark. Dan Med J. 2018 Apr;65(4):B5454. PMID: 29619932 59. Radunovic Z, Steine K. Prevalence of Cardiovascular Disease and Cardiac Symptoms: Left and Right Ventricular Function in Adults With Osteogenesis Imperfecta. Can J Cardiol. 2015 Nov;31(11):1386-92 60. Ashournia H, Johansen FT, Folkestad L, Diederichsen AC, Brixen K. Heart disease in patients with osteogenesis imperfecta - A systematic review. Int J Cardiol. 2015 Oct 1;196:149-57 61. Lafage-Proust MH, Courtois I. The management of osteogenesis imperfecta in adults: state of the art. Joint Bone Spine. 2019 Oct;86(5):589-593. doi: 10.1016/j.jbspin.2019.02.001. Epub 2019 Feb 8. PMID: 30742929 62. Steiner R, Adsit J, Basel D. COL1A1/2-Related Osteogenesis Imperfecta. Ncbinlmnihgov. 2018. Available at: https://www.ncbi.nlm.nih.gov/books/NBK1295. Accessed June 22, 2018; 63. Kuurila K, Grénman R, Johansson R, Kaitila I. Hearing loss in children with osteogenesis imperfecta. Eur J Pediatr. 2000 Jul;159(7):515-9 64. Swinnen FK, Dhooge IJ, Coucke PJ, D'Eufemia P, Zardo F, Garretsen TJ, Cremers CW, De Leenheer EM. Audiologic phenotype of osteogenesis imperfecta: use in clinical differentiation. Otol Neurotol. 2012 Feb;33(2):115-22 65. Игнатович О.Н., Намазова-Баранова Л.С., Маргиева Т.В., Яхяева Г.Т., Журкова Н.В., Савостьянов К.В., Пушков А.А., & Кротов И.А. (2018). Несовершенный остеогенез: особенности диагностики. Педиатрическая фармакология, 15 (3), 224-232 66. Tauer JT, Robinson ME, Rauch F. Osteogenesis Imperfecta: New Perspectives From Clinical and Translational Research. JBMR Plus. 2019 Feb 20;3(8):e10174 59 67. Eichhorn J.H., Cooper J.B., Cullen D.J. et al. Standarts of patient monitoring during anesthesia at Harvard Medical School // J Am Med Ass. - 1986. - Vol. 256. - PP. 1017-1020. 68. Osteogenesis imperfecta: An overview John F Beary, III, MD last updated: May 04, 2021 https://www.uptodate.com/contents/osteogenesis-imperfecta-anoverview?search=Approach%20to%20prenatal%20diagnosis%20of%20the%20lethal%20skeletal%2 0dysplasias&topicRef=14209&source=related_link 69. Salvatori, G., Foligno, S. Minerals and extremely low birth weight infants. Ital J Pediatr 41, A37 (2015). https://doi.org/10.1186/1824-7288-41-S1-A37 70. Garganta M.D., Jaser S.S., Lazow M.A., Schoenecker J.G., Cobry E., Hays S.R., Simmons J.H. Cyclic bisphosphonate therapy reduces pain and improves physical functioning in children with osteogenesis imperfecta. BMC Musculoskelet Disord. 2018 Sep 24;19(1):344. doi: 10.1186/s12891- 018-2252-y. 71. Bains J.S., Carter E.M., Citron K.P., Boskey A.L., Shapiro J.R., Steiner R.D., Smith P.A., Bober M.B., Hart T., Cuthbertson D., Krischer J., Byers P.H., Pepin M., Durigova M., Glorieux F.H., Rauch F., Sliepka J.M., Sutton V.R., Lee B., Members of the BBD Consortium, Nagamani S.C., Raggio C.L. A Multicenter Observational Cohort Study to Evaluate the Effects of Bisphosphonate Exposure on Bone Mineral Density and Other Health Outcomes in Osteogenesis Imperfecta. JBMR Plus. 2019 Jan 7;3(5):e10118. doi: 10.1002/jbm4.10118. 72. Cuevas-Olivo R., Alejo-Fuentes L.J., Alejo-Fuentes L.F., Campos-Angulo G. Treatment with bisphosphonates improves the quality of life in patients with diagnosis of osteogenesis imperfecta. Acta Ortop Mex. 2019 Mar-Apr;33(2):63-66. 73. Dwan K, Phillipi CA, Steiner RD, Basel D. Bisphosphonate therapy for osteogenesis imperfecta. Cochrane Database Syst Rev. 2016 Oct 19;10(10):CD005088. doi: 10.1002/14651858.CD005088.pub4 74. Яхяева Г.Т. Научное обоснование новых подходов к диагностике и лечению несовершенного остеогенеза у детей дисс. канд. мед. наук Москва 2016: 127с. 75. Płudowski P, Karczmarewicz E, Bayer M, Carter G, Chlebna-Sokół D, Czech-Kowalska J, Dębski R, Decsi T, Dobrzańska A, Franek E, Głuszko P, Grant WB, Holick MF, Yankovskaya L, Konstantynowicz J, Książyk JB, Księżopolska-Orłowska K, Lewiński A, Litwin M, Lohner S, Lorenc RS, Lukaszkiewicz J, Marcinowska-Suchowierska E, Milewicz A, Misiorowski W, Nowicki M, Povoroznyuk V, Rozentryt P, Rudenka E, Shoenfeld Y, Socha P, Solnica B, Szalecki M, Tałałaj M, Varbiro S, Żmijewski MA. Practical guidelines for the supplementation of vitamin D and the 60 treatment of deficits in Central Europe - recommended vitamin D intakes in the general population and groups at risk of vitamin D deficiency. Endokrynol Pol. 2013;64(4):319-27 76. Barros E. R., Saraiva G. L., de Oliveira T. P., Lazaretti-Castro M. Safety and efficacy of a 1- year treatment with zoledronic acid compared with pamidronate in children with osteogenesis imperfect. J Pediatr Endocrinol Metab. 2012; 25 (5–6): 485–91. 77. Cadarette S.M., Katz J.N., Brookhart M.A., Stürmer T., Stedman M.R., Levin R., Solomon D.H. Comparative gastrointestinal safety of weekly oral bisphosphonates. Osteoporos Int. 2009 Oct;20(10):1735-47. doi: 10.1007/s00198-009-0871-8. 78. Tadrous M., Wong L., Mamdani M.M., Juurlink D.N., Krahn M.D., Lévesque L.E., Cadarette S.M. Comparative gastrointestinal safety of bisphosphonates in primary osteoporosis: a network meta-analysis. Osteoporos Int. 2014 Apr;25(4):1225-35. doi: 10.1007/s00198-013-2576-2. 79. Modi A., Siris E.S., Steve Fan C.P., Sajjan S. Gastrointestinal Events Among Patients Initiating Osteoporosis Therapy: A Retrospective Administrative Claims Database Analysis. Clin Ther. 2015 Jun 1;37(6):1228-34. doi: 10.1016/j.clinthera.2015.03.018. 80. Panigrahi I., Das R.R., Sharda S., Marwaha R.K., Khandelwal N. Response to zolendronic acid in children with type III osteogenesis imperfecta. J Bone Miner Metab. 2010 Jul;28(4):451-5. 81. Vuorimies I., Toiviainen-Salo S., Hero M., Mäkitie O. Zoledronic Acid Treatment in Children with Osteogenesis Imperfecta. Hormone Research in Paediatrics. 2011;75:346–353. 82. Sánchez-Sánchez L.M., Cabrera-Pedroza A.U., Palacios-Saucedo G.C., Fuente-de la Cortez B. Zoledronic acid (zoledronate) in children with osteogenesis imperfecta. Gaceta medica de Mexico 2015; 151: 152-6. 83. Otaify G.A., Aglan M.S., Ibrahim M.M., Elnashar M., El Banna R.A., Temtamy S.A. Zoledronic acid in children with osteogenesis imperfecta and Bruck syndrome: a 2-year prospective observational study. Osteoporos Int. 2016 Jan;27(1):81-92. 84. Kumar C., Panigrahi I., Aradhya S., A., Meena B. L., Khandelwal N. Zoledronate for Osteogenesis imperfecta: evaluation of safety profile in children. J Pediatr Endocrinol Metab. 2016 Aug 1;29(8):947-52. 85. Lv F, Liu Y, Xu X, Song Y, Li L, Jiang Y, Wang O, Xia W, Xing X. Zoledronic acid versus alendronate in the treatment of children with osteogenesis imperfecta: a 2-year clinical study. Endocr Pract. 2018 Feb;24(2):179-188. 61 86. Glorieux F.H., Bishop N.J., Plotkin H., Chabot G., Lanoue G., Travers R. Cyclic administration of pamidronate in children with severe osteogenesis imperfecta. N Engl J Med. 1998 Oct 1;339(14):947-52. 87. Яхяева Г.Т., Намазова-Баранова Л.С., Маргиева Т.В. Опыт применения памидроновой кислоты в терапии у детей с несовершенным остеогенезом. Российский педиатрический журнал. 2016; 19 (5): 282-287. DOI: 10.18821/1560-9561-2016-19 (5)-282-287. 88. D'Astous J. L., Sanders J. O. Casting and traction treatment methods for scoliosis //Orthopedic Clinics of North America. – 2007. – Т. 38. – №. 4. – С. 477-484.; 89. Sanders J. O. et al. Derotational casting for progressive infantile scoliosis //Journal of Pediatric Orthopaedics. – 2009. – Т. 29. – №. 6. – С. 581-587.; Yang S. et al. Early-onset scoliosis: a review of history, current treatment, and future directions //Pediatrics. – 2016. – Т. 137. – №. 1. – С. e20150709.; 90. Thorsness R. J. et al. Nonsurgical management of early-onset scoliosis //JAAOS-Journal of the American Academy of Orthopaedic Surgeons. – 2015. – Т. 23. – №. 9. – С. 519-528; 91. Baulesh DM, Huh J, Judkins T, Garg S, Miller NH, Erickson MA. The role of serial casting in early-onset scoliosis (EOS). J Pediatr Orthop. 2012 Oct-Nov;32(7):658-63. doi: 10.1097/BPO.0b013e318269c438. PMID: 22955527 92. Glorieux FH: Osteogenesis imperfecta. Best Pract Res Clin Rheum 2008; 22: 85–100 93. Rauch F, Glorieux FH. Osteogenesis imperfecta. 2004, Lancet, 363:1377–1385 94. Zeitlin L, Fassier F, Glorieux FH. Modern approach to children with osteogeneis imperfecta. J Pediatr Orthop. 2003. 12B:77–87 95. Fassier F, Sardar Z, Aarabi M, Odent T, Haque T, Hamdy R. Results and complications of a surgical technique for correction of coxa vara in children with osteopenic bones. J Pediatr Orthop. 2008 Dec; 28(8):799-805 96. Rodriguez Celin M, Kruger KM, Caudill A, Nagamani SCS; Brittle Bone Disorders Consortium (BBDC); Linked Clinical Research Centers (LCRC), Harris GF, Smith PA. A Multicenter Study of Intramedullary Rodding in Osteogenesis Imperfecta. JBJS Open Access. 2020 Sep 11;5(3):e20.00031 97. Bregou Bourgeois A, Aubry-Rozier B, Bonafé L, Laurent Applegate L, Pioletti DP, Zambelli PY. Osteogenesis imperfecta: from diagnosis and multidisciplinary treatment to future perspectives. Swiss Med Wkly 2016 ; 146 : w14322 98. Pavón de Paz I, Rosado Sierra JA, Pérez Blanco C, Modroño Móstoles N, Guijarro de Armas G, Navea Aguilera C. Acute and long-term effects of zoledronate in adult patients with osteogenesis 62 imperfecta. An observational Spanish study with five years of follow-up. Endocrinol Diabetes Nutr (Engl Ed). 2019 Feb;66(2):108-116. English, Spanish. doi: 10.1016/j.endinu.2018.05.015 99. Activities and participation in young adults with osteogenesis imperfecta / K. Montpetit, N. Dahan-Oliel, J. Ruck-Gibis, F. Fassier, F. Rauch, F. Glorieux // J. Pediatr. Rehabil. Med. 2011. Vol. 4, N 1. P. 13-22, 100. From pediatric to adult care: strategic evaluation of a transition program for patients with osteogenesis imperfect / M.J. Dogba, F. Rauch, T. Wong, J. Ruck, F.H. Glorieux, C. Bedos // BMC Health Serv. Res. 2014. Vol. 14. P. 489 101. Multidisciplinary treatment of severe osteogenesis imperfecta: functional outcomes at skeletal maturity / K. Montpetit, T. Palomo, F.H. Glorieux, F. Fassier, F. Rauch // Arch. Phys. Med. Rehabil. 2015. Vol. 96, N 10. P. 1834-1839 102. Marini J.C., Forlino A., Bächinger H.P., Bishop N.J., Byers P.H., Paepe A., Fassier F., FratzlZelman N., Kozloff K.M., Krakow D., Montpetit K., Semler O. Osteogenesis imperfecta. Nat. Rev. Dis. Primers, 2017, vol. 3, pp. 17052. DOI: 10.1038/nrdp.2017.52 103. Oberc A, Sułko J. Limitations in Use of Elastic Stable Intramedullary Nailing (ESIN) in Children with Disorders of Bone Mineralization. Ortop Traumatol Rehabil. 2020; 22(2):77-83 104. Spahn K.M., Mickel T., Carry P.M., Brazell C.J., Whalen K., Georgopoulos G., Miller N.H. Fassier-Duval Rods are Associated With Superior Probability of Survival Compared With Static Implants in a Cohort of Children With Osteogenesis Imperfecta Deformities. J Pediatr Orthop. 2019 May/Jun;39(5):e392-e396. doi: 10.1097/BPO.0000000000001324. 105. A standard set of outcome measures for the comprehensive assessment of osteogenesis imperfecta/Nijhuis et al. Orphanet J Rare Dis (2021) 16:140 https://doi.org/10.1186/s13023-021- 01682-y 106. Kokavec M, Novorolský K, Pribilincová Z. Moznost interdisciplinárneho ovplyvnenia hojenia zlomenín dlhých kostí u osteogenesis imperfecta [Role of an interdisciplinary approach in the healing of long bone fractures in patients with osteogenesis imperfecta]. Acta Chir Orthop Traumatol Cech. 2008 Jun;75(3):185-9. Slovak. PMID: 18601816 107. Sakkers RJ, Montpetit K, Tsimicalis A, Wirth T, Verhoef M, Hamdy R, Ouellet JA, Castelein RM, Damas C, Janus GJ, Nijhuis WH, Panzeri L, Paveri S, Mekking D, Thorstad K, Kruse RW. A roadmap to surgery in osteogenesis imperfecta: results of an international collaboration of patient organizations and interdisciplinary care teams. Acta Orthop. 2021 Oct;92(5):608-614. doi: 10.1080/17453674.2021.1941628. Epub 2021 Jun 28. PMID: 34180749; PMCID: PMC8519518. 108. Monti E., Mottes M., Fraschini P., Brunelli P., Forlino A., Venturi G., Doro F., Perlini S., Cavarzere P., Antoniazzi F. Current and emerging treatments for the management of osteogenesis imperfecta. Ther Clin Risk Manag. 2010 Sep 7;6:367-81. 63 109. Ruck J., Dahan-Oliel N., Montpetit K., Rauch F., Fassier F. Fassier-Duval femoral rodding in children with osteogenesis imperfecta receiving bisphosphonates: functional outcomes at one year. J Child Orthop. 2011 Jun;5(3):217-24. doi: 10.1007/s11832-011-0341-7 110. Lin T.Y., Yang C.Y., Liu S.C. Corrective osteotomy with retrograde Fassier-Duval nail in an osteogenesis imperfecta patient with bilateral genu valgum: A case report. Medicine (Baltimore). 2017 Nov;96(47):e8459. doi: 10.1097/MD.0000000000008459. 111. Azzam K.A., Rush E.T., Burke B.R., Nabower A.M., Esposito P.W. Mid-term Results of Femoral and Tibial Osteotomies and Fassier-Duval Nailing in Children With Osteogenesis Imperfecta. J Pediatr Orthop. 2018 Jul;38(6):331-336. doi: 10.1097/BPO.0000000000000824. 112. Shin C. H., Lee D. J., Yoo W. J., Choi I. H., Cho, T.-J. (2018). Dual Interlocking Telescopic Rod Provides Effective Tibial Stabilization in Children With Osteogenesis Imperfecta. Clin Orthop Relat Res. 2018 Nov; 476(11): 2238–2246. doi:10.1097/corr.0000000000000429. 113. Persiani P., Ranaldi F.M., Martini L., Zambrano A., Celli M., D'Eufemia P., Villani C. Treatment of tibial deformities with the Fassier-Duval telescopic nail and minimally invasive percutaneous osteotomies in patients with osteogenesis imperfecta type III. J Pediatr Orthop B. 2019 Mar;28(2):179-185. doi: 10.1097/BPB.0000000000000536. 114. Fassier FR. Osteogenesis Imperfecta-Who Needs Rodding Surgery? Curr Osteoporos Rep. 2021 Jun;19(3):264-270. doi: 10.1007/s11914-021-00665-z 115. Sabharwal S. Pediatric Lower Limb Deformities: Principles and techniques of management. 1st ed.New York, NY: Springer International Publishing Switzerland; 2016 [Google Scholar] 116. Franzone JM, Bober MB, Rogers KJ, McGreal CM, Kruse RW. Re-alignment and intramedullary rodding of the humerus and forearm in children with osteogenesis imperfecta: revision rate and effect on fracture rate. J Child Orthop. 2017;11(3):185–90 117. Wirth T. The orthopaedic management of long bone deformities in genetically and acquired generalized bone weakening conditions. J Child Orthop. 2019;13(1):12–21 118. Hidalgo Perea S, Green DW. Osteogenesis imperfecta: treatment and surgical management. Curr Opin Pediatr. 2021 Feb 1;33(1):74-78. doi: 10.1097/MOP.0000000000000968. PMID: 33278111 119. Popkov D, Dolganova T, Mingazov E, Dolganov D, Kobyzev A. Combined technique of titanium telescopic rods and external fixation in osteogenesis imperfecta patients: First 12 consecutive cases. J Orthop. 2020 Jun 20;22:316-325 64 120. El-Adl G, Khalil MA, Enan A, Mostafa MF, El-Lakkany MR. Telescoping versus nontelescoping rods in the treatment of osteogenesis imperfecta. Acta Orthop Belg. 2009 Apr;75(2):200- 8. PMID: 19492559.] 121. Makhdom AM, Kishta W, Saran N, Azouz M, Fassier F. Are Fassier-Duval rods at risk of migration in patients undergoing spine magnetic resonance imaging? J Pediatr Orthop. 2015 AprMay;35(3):323-7. doi: 10.1097/BPO.0000000000000256 122. Ong N, Zailan I, Tandon A. Imaging update in arthroplasty. J Clin Orthop Trauma. 2021 Oct 21;23:101649. doi: 10.1016/j.jcot.2021.101649. PMID: 34777990 123. Boutaud B, Laville JM. L’embrochage centromédullaire coulissant dans l’ostéogenèse imparfaite. Rev Chir Orthop. 2004. 90:304–311 124. Persiani, P., Martini, L., Ranaldi, F.M., Zambrano, A., Celli, M., Celli, L., D'Eufemia, P., Villani, C. (2019). Elastic intramedullary nailing of the femur fracture in patients affected by osteogenesis imperfecta type 3: Indications, limits and pitfalls. Injury, Suppl 2:S52-S56 125. Popkov, D., Popkov, A., Mingazov, E. (2019). Use of sliding transphyseal flexible intramedullary nailing in pediatric osteogenesis imperfecta patients. Acta Orthop Belg, 85(1):1-11 126. Langlais, T., Pannier, S., De Tienda, M., Dukan, R., Finidori, G., Glorion, C., Péjin, Z. (2021). 'In-Out-In' K-wires sliding in severe tibial deformities of osteogenesis imperfecta: a technical note. J Pediatr Orthop B. 30(3):257-2 127. Agarwal V., Joseph B. Non-union in osteogenesis imperfecta. J PediatrOrthop B 2005; 14:451–455, doi: 10.1097/01202412-200511000-00013. 128. Pichard C.P., Robinson R.E., Skolasky R.L., Fedarko N.S., Leet A.I. Surgical blood loss during femoral rodding in children with osteogenesis imperfecta. J Child Orthop 2009; 3:301–305. 129. Anam E.A., Rauch F., Glorieux F.H., Fassier F., Hamdy R. Osteotomy healing in children with osteogenesis imperfecta receiving bisphosphonate treatment. J Bone Miner Res 2015; 30:1362– 1368, doi: 10.1002/jbmr.2486. 130. Birke O., Davies N., Latimer M., Little D.G., Bellemore M. Experience with the FassierDuval telescopic rod: first 24 consecutive cases with a minimum of 1-year follow-up. J Pediatr Orthop. 2011;31:458–464, doi: 10.1097/BPO.0b013e31821bfb50. 131. Fassier F, Esposito P, Sponseller PD, Smith P., Sussman M., Sundberg S., Ruck-Gibis J., Ruck-Gibis T. Multicenter Radiological Assessment of the Fassier-Duval Femoral Rodding. San 65 Diego, CA: Proceedings of the Annual Meeting of the Pediatric Orthopaedic Society of North America (POSNA); 2006. 132. Abulsaad M., Abdelrahman A. Modified Sofield-Millar operation: less invasive surgery of lower limbs in osteogenesis imperfecta. Int Orthop 2009; 33:527–532, doi: 10.1007/s00264-008- 0515-1. 133. Enright WJ, Noonan KJ. Bone plating in patients with type III osteogenesis imperfecta: results and complications. Iowa Orthop J. 2006;26:37-40. PMID: 16789446; PMCID: PMC1888596. 134. Franzone JM, Kruse RW. Intramedullary nailing with supplemental plate and screw fixation of long bones of patients with osteogenesis imperfecta: operative technique and preliminary results. J Pediatr Orthop B. 2018 Jul;27(4):344-349. doi: 10.1097/BPB.0000000000000405. PMID: 27832015 135. Cho TJ, Lee K, Oh CW, Park MS, Yoo WJ, Choi IH. Locking plate placement with unicortical screw fixation adjunctive to intramedullary rodding in long bones of patients with osteogenesis imperfecta. J Bone Joint Surg Am. 2015 May 6;97(9):733-7. doi: 10.2106/JBJS.N.01185. PMID: 25948520 136. Hsiao MS, Mormino MA, Esposito PW, Burke BA. Distal humerus atrophic nonunion in a child with osteogenesis imperfecta. J Pediatr Orthop. 2013 Oct-Nov;33(7):725-9. doi: 10.1097/BPO.0b013e3182a32e69. PMID: 23965914. 137. Birke O, Davies N, Latimer M, Little DG, Bellemore M. Experience with the Fassier-Duval telescopic rod: first 24 consecutive cases with a minimum of 1-year follow-up. J Pediatr Orthop. 2011 Jun;31(4):458-464; Popkov D 138. Balanescu R., Ulici A., Rosca D., Topor L., Barbu M. Use of minimally invasive (percutaneous) Fassier-Duval telescopic rod on an 8 year old patient with Lobstein disease. Chirurgia (Bucur). 2013;108:120–125. 139. Folkestad L, Hald JD, Ersbøll AK, Gram J, Hermann AP, Langdahl B, Abrahamsen B, Brixen K. Fracture Rates and Fracture Sites in Patients With Osteogenesis Imperfecta: A Nationwide Register-Based Cohort Study. J Bone Miner Res. 2017 Jan;32(1):125-134 140. Georgescu I, Gavriliu Ș, Nepaliuc I, Munteanu L, Țiripa I, Ghiță R, Japie E, Hamei S, Dughilă C, Macadon M. Burnei's technique of femoral neck variation and valgisation by using the intramedullary rod in Osteogenesis imperfecta. J Med Life. 2014 Oct-Dec;7(4):493-498 141. Sinikumpu J.J., Ojaniemi M., Lehenkari P., Serlo W. Severe osteogenesis imperfecta Type-III and its challenging treatment in newborn and preschool children. A systematic review. Injury. 2015 Aug;46(8):1440-6. doi: 10.1016/j.injury.2015.04.021. 66 142. Violas P, Mary P. Imperfecta osteogenesis: interest of surgical treatment. Arch Pediatr 2008 ; 15 : 794-796 143. Sterian A, Balanescu R, Barbilian A, Tevanov I, Carp M, Nahoi C, Barbu M, Ulici A. Early telescopic rod osteosynthesis for Osteogenesis Imperfecta patients. J Med Life 2015 ; 544-547 144. Fritz JM, Guan Y, Wang M, et al.: A fracture risk assessment model of the femur in children with osteogenesis imperfecta (OI) during gait. Med Eng Phys. 2009; 31(9): 1043–8 145. Fritz JM, Guan Y, Wang M, et al.: Muscle force sensitivity of a finite element fracture risk assessment model in osteogenesis imperfecta - biomed 2009. Biomed Sci Instrum. 2009; 45: 316–21 146. Caouette C, Rauch F, Villemure I, et al.: Biomechanical analysis of fracture risk associated with tibia deformity in children with osteogenesis imperfecta: a finite element analysis. J Musculoskelet Neuronal Interact. 2014; 14(2): 205–12. 147. Ashby E, Montpetit K, Hamdy RC, Fassier F. Functional Outcome of Humeral Rodding in Children With Osteogenesis Imperfecta. J Pediatr Orthop. 2018 Jan;38(1):49-53 148. Laron D, Pandya NK. Advances in the orthopedic management of osteogenesis imperfecta Orthop Clin North Am. 2013 Oct;44(4):565-73 149. Roberts TT, Cepela DJ, Uhl RL, Lozman J. Orthopaedic Considerations for the Adult With Osteogenesis Imperfecta. J Am Acad Orthop Surg. 2016 May;24(5):298-308 150. Gil JA, DeFroda SF, Sindhu K, Cruz AI Jr, Daniels AH. Challenges of Fracture Management for Adults With Osteogenesis Imperfecta. Orthopedics. 2017 Jan 1;40(1):e17-e22 151. Bishop NJ. Walsh JS. Osteogenesis imperfecta in adults. J Clin Invest, 2014, 124:476–477 152. Kocher MS, Shapiro F: Osteogenesis imperfecta. J Am Acad Orthop Surg 1998;6 (4):225-236 153. Yilmaz G, Hwang S, Oto M, et al: Surgical treatment of scoliosis in osteogenesis imperfecta with cement- augmented pedicle screw instrumentation. J Spinal Disord Tech 2014;27(3):174-180 154. Skaggs D. L. et al. A classification of growth friendly spine implants //Journal of Pediatric Orthopaedics. – 2014. – Т. 34. – №. 3. – С. 260-274 155. Campbell Jr R. M., Smith M. D. Thoracic insufficiency syndrome and exotic scoliosis //JBJS. – 2007. – Т. 89. – №. suppl_1. – С. 108-122 67 156. Wijdicks S. P. J. et al. A comparison of growth among growth-friendly systems for scoliosis: a systematic review //The Spine Journal. – 2019. – Т. 19. – №. 5. – С. 789-799. 157. Widmann RF, Bitan FD, Laplaza FJ, Burke SW, DiMaio MF, Schneider R. Spinal deformity, pulmonary compromise, and quality of life in osteogenesis imperfecta Spine (Phila Pa 1976). 1999 Aug 15;24(16):1673-8. doi: 10.1097/00007632-199908150-00008. 158. Ibrahim A. G., Crockard H. A. (2007). Basilar impression and osteogenesis imperfecta: a 21- year retrospective review of outcomes in 20 patients. Journal of Neurosurgery: Spine, 7(6), 594–600. doi:10.3171/spi-07/12/594 159. Antoniazzi F, Mottes M, Fraschini P, Brunelli PC, Tatò L. Osteogenesis imperfecta: practical treatment guidelines. Paediatr Drugs. 2000 Nov-Dec;2(6):465-88. doi: 10.2165/00128072- 200002060-00005. PMID: 11127846 160. Marini J.C., Hopkins E., Glorieux F.H., Chrousos G.P., Reynolds J.C., Gundberg C.M., Reing C.M. Positive linear growth and bone responses to growth hormone treatment in children with types III and IV osteogenesis imperfecta: high predictive value of the carboxyterminal propeptide of type I procollagen. J Bone Miner Res 2003; 18:237. 161. https://www.uptodate.com/contents/osteogenesis-imperfecta-management-andprognosis/abstract/56 Antoniazzi F, Monti E, Venturi G, Franceschi R, Doro F, Gatti D, Zamboni G, Tatò L. GH in combination with bisphosphonate treatment in osteogenesis imperfecta. Eur J Endocrinol. 2010 Sep;163(3):479-87 69, 70 162. Pain Management https://oif.org/wp-content/uploads/2019/08/Pain_Management.pdf, 163. Ricki S. Carroll,Perri Donenfeld,Cristina McGreal,Jeanne M. Franzone,Richard W. Kruse,Catherine Preedy,Joanna Costa,Daniel R. Dirnberger,Michael B. Bober Comprehensive pain management strategy for infants with moderate to severe osteogenesis imperfecta in the perinatal period. Paediatric and neonatal pain. Volume3, Issue4 December 2021 Pages 156- 162https://doi.org/10.1002/pne2.12066 164. Tracy Nghiem , Khadidja Chougui , Alisha Michalovic , Chitra Lalloo , Jennifer Stinson , Marie-Elaine Lafrance , Telma Palomo , Noémi Dahan-Oliel & Argerie Tsimicalis (2018) Pain experiences of adults with osteogenesis imperfecta: An integrative review, Canadian Journal of Pain, 2:1, 9-20, DOI: 10.1080/24740527.2017.1422115 165. https://www.england.nhs.uk/wp-content/uploads/2018/07/Teriparatide-for-the-treatment-ofosteogenesis-imperfecta-adults.pdf 166. Kobayashi T, Nakamura Y, Suzuki T, Yamaguchi T, Takeda R, Takagi M, Hasegawa T, Kosho T, Kato H. Efficacy and Safety of Denosumab Therapy for Osteogenesis Imperfecta Patients 68 with Osteoporosis—Case Series. Journal of Clinical Medicine. 2018; 7(12):479. https://doi.org/10.3390/jcm7120479 167. Suzuki T, Nakamura Y, Kato H. Vitamin D and Calcium Addition during Denosumab Therapy over a Period of Four Years Significantly Improves Lumbar Bone Mineral Density in Japanese Osteoporosis Patients. Nutrients. 2018; 10(3):272. https://doi.org/10.3390/nu10030272 168. Sabir, A.H., Cole, T. The evolving therapeutic landscape of genetic skeletal disorders. Orphanet J Rare Dis 14, 300 (2019). https://doi.org/10.1186/s13023-019-1222-2 169. Ralston SH, Gaston MS. Management of Osteogenesis Imperfecta. Front Endocrinol (Lausanne). 2020 Feb 11;10:924 170. Бурцев М.Е., Фролов А.В., Логвинов А.Н., и др. Современный подход к диагностике и лечению детей с несовершенным остеогенезом // Ортопедия, травматология и восстановительная хирургия детского возраста. - 2019. - Т. 7. - №2. - C. 87-102 171. https://www.physio-pedia.com/Osteogenesis_Imperfecta 172. Mueller B, Engelbert R, Baratta-Ziska F, Bartels B, Blanc N, Brizola E, Fraschini P, Hill C, Marr C, Mills L, Montpetit K, Pacey V, Molina MR, Schuuring M, Verhille C, de Vries O, Yeung EHK, Semler O. Consensus statement on physical rehabilitation in children and adolescents with osteogenesis imperfecta. Orphanet J Rare Dis. 2018 Sep 10;13(1):158 173. Osteogenesis Imperfecta Joan C. Marini, An N. Dang Do https://www.ncbi.nlm.nih.gov/books/NBK279109/ (Last Update: July 26, 2020.) 174. Cubert R., Cheng E.Y., Mack S., Pepin M.G., Byers P.H. Osteogenesis imperfecta: mode of delivery and neonatal outcome. Obstet Gynecol 2001; 97: 66–69. doi: 10.1016/s0029- 7844(00)01100-5. 175. Bellur S., Jain M., Cuthbertson D., Krakow D., Shapiro J. R., Steiner R.D., Smith P.A., Bober M.B., Hart T., Krischer J., Mullins M., Byers P.H., Pepin M., Durigova M., Glorieux F.H., Rauch F., Sutton V.R., Lee B., Members of the BBD Consortium, Nagamani, S. C. (2015). Cesarean delivery is not associated with decreased at-birth fracture rates in osteogenesis imperfecta. Genetics in Medicine, 18(6), 570–576. doi:10.1038/gim.2015.131. 176. Pabinger C, Heu C, Frohner A, Dimai HP (2012) Pregnancy and lactation-associated transient osteoporosis of both hips in a 32 year old patient with osteogenesis imperfecta. Bone 51(1):142–144. doi: 10.1016/j.bone.2012.04.013. 177. Chan B., Zacharin M. (2006) Maternal and infant outcome after pamidronate treatment of polyostotic fibrous dysplasia and osteogenesis imperfecta before conception: a report of four cases. J Clin Endocrinol Metab 91(6):2017–2020. doi: 10.1210/jc.2005-2548. 69 178. Murray S., Shamsuddin W., Russell R. (2011) Sequential combined spinal-epidural for caesarean delivery in osteogenesis imperfecta. Int J Obstet Anesth 19(1):127–128. doi: 10.1016/j.ijoa.2009.07.009. 179. Benbara A., Sellier N., Benchimol M., Carbillon L. (2010) Incomplete abortion at 13 weeks’ gestation due to extreme pelvic deformity in a woman with severe osteogenesis imperfecta. J Obstet Gynaecol 30(2):196–198. doi: 10.3109/01443610903440919. 180. Fiegel M.J. (2011) Cesarean delivery and colon resection in a patient with type III osteogenesis imperfect. Semin Cardiothorac Vasc Anesth 15(3):98–101 doi: 10.1177/1089253211412978.